Sutter West Bay Hospitals
Records under this name other than patents Sutter West Bay Hospitals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Sutter West Bay Hospitals
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,280,466 | Method and kit for dynamic gene expression monitoring Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,084,771 | Methods and compositions for treating cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,202,322 | Resorcinol Derivatives Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,260,043 | Methods and compositions for treating cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,254,272 | Resorcinol derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,142,796 | MIR-18B for use as a marker of cancer progression and target for therapies to treat cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,526,662 | Falz for Use as a Target for Therapies to Treat Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 9,920,377 | Falz for Use as a Target for Therapies to Treat Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,332,792 | Mitochondrial DNA mutation profile for predicting human health conditions and disease risk and for monitoring treatments Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,883,440 | Method to Predict or Diagnose a Gastrointestinal Disorder or Disease Formerly held Grace period ended · Low confidence | Grace period ended | Low confidence |